# RABEPRAZOLE SODIUM
> **ANDA204237** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2015-11-18
## Drug
- **FDA Application Number:** ANDA204237
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RABEPRAZOLE SODIUM
- **Generic name:** RABEPRAZOLE SODIUM
- **Active ingredients:** RABEPRAZOLE SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Limited
- **First approval:** 2015-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204237)
---
*MORVS · CC0 1.0*